First Header Logo Second Header Logo

Connection

Debra Diz to Kidney

This is a "connection" page, showing publications Debra Diz has written about Kidney.
Connection Strength

1.690
  1. Diz DI. Lewis K. Dahl memorial lecture: the renin-angiotensin system and aging. Hypertension. 2008 Jul; 52(1):37-43.
    View in: PubMed
    Score: 0.231
  2. Gilliam-Davis S, Payne VS, Kasper SO, Tommasi EN, Robbins ME, Diz DI. Long-term AT1 receptor blockade improves metabolic function and provides renoprotection in Fischer-344 rats. . 2007 Sep; 293(3):H1327-33.
    View in: PubMed
    Score: 0.218
  3. Kasper SO, Basso N, Kurnjek ML, Paglia N, Ferrario CM, Ferder LF, Diz DI. Divergent regulation of circulating and intrarenal renin-angiotensin systems in response to long-term blockade. Am J Nephrol. 2005 Jul-Aug; 25(4):335-41.
    View in: PubMed
    Score: 0.189
  4. Clark MA, Tallant EA, Tommasi E, Bosch S, Diz DI. Angiotensin-(1-7) reduces renal angiotensin II receptors through a cyclooxygenase-dependent mechanism. J Cardiovasc Pharmacol. 2003 Feb; 41(2):276-83.
    View in: PubMed
    Score: 0.160
  5. Allred AJ, Chappell MC, Ferrario CM, Diz DI. Differential actions of renal ischemic injury on the intrarenal angiotensin system. Am J Physiol Renal Physiol. 2000 Oct; 279(4):F636-45.
    View in: PubMed
    Score: 0.136
  6. South AM, Nixon PA, Chappell MC, Diz DI, Russell GB, Jensen ET, Shaltout HA, O'Shea TM, Washburn LK. Renal function and blood pressure are altered in adolescents born preterm. Pediatr Nephrol. 2019 01; 34(1):137-144.
    View in: PubMed
    Score: 0.118
  7. Benter IF, Yousif MH, Al-Saleh FM, Raghupathy R, Chappell MC, Diz DI. Angiotensin-(1-7) blockade attenuates captopril- or hydralazine-induced cardiovascular protection in spontaneously hypertensive rats treated with NG-nitro-L-arginine methyl ester. J Cardiovasc Pharmacol. 2011 May; 57(5):559-67.
    View in: PubMed
    Score: 0.071
  8. Gwathmey TM, Shaltout HA, Rose JC, Diz DI, Chappell MC. Glucocorticoid-induced fetal programming alters the functional complement of angiotensin receptor subtypes within the kidney. Hypertension. 2011 Mar; 57(3):620-6.
    View in: PubMed
    Score: 0.070
  9. Gwathmey TM, Westwood BM, Pirro NT, Tang L, Rose JC, Diz DI, Chappell MC. Nuclear angiotensin-(1-7) receptor is functionally coupled to the formation of nitric oxide. Am J Physiol Renal Physiol. 2010 Nov; 299(5):F983-90.
    View in: PubMed
    Score: 0.068
  10. Gwathmey TM, Shaltout HA, Pendergrass KD, Pirro NT, Figueroa JP, Rose JC, Diz DI, Chappell MC. Nuclear angiotensin II type 2 (AT2) receptors are functionally linked to nitric oxide production. Am J Physiol Renal Physiol. 2009 Jun; 296(6):F1484-93.
    View in: PubMed
    Score: 0.061
  11. Benter IF, Yousif MH, Anim JT, Cojocel C, Diz DI. Angiotensin-(1-7) prevents development of severe hypertension and end-organ damage in spontaneously hypertensive rats treated with L-NAME. . 2006 Feb; 290(2):H684-91.
    View in: PubMed
    Score: 0.049
  12. Pendergrass KD, Averill DB, Ferrario CM, Diz DI, Chappell MC. Differential expression of nuclear AT1 receptors and angiotensin II within the kidney of the male congenic mRen2. Lewis rat. Am J Physiol Renal Physiol. 2006 Jun; 290(6):F1497-506.
    View in: PubMed
    Score: 0.049
  13. Robbins ME, Diz DI. Pathogenic role of the renin-angiotensin system in modulating radiation-induced late effects. Int J Radiat Oncol Biol Phys. 2006 Jan 01; 64(1):6-12.
    View in: PubMed
    Score: 0.049
  14. Diz DI, Nasjletti A, Baer PG. Renal denervation at weaning retards development of hypertension in New Zealand genetically hypertensive rats. Hypertension. 1982 May-Jun; 4(3):361-8.
    View in: PubMed
    Score: 0.038
  15. Allred AJ, Diz DI, Ferrario CM, Chappell MC. Pathways for angiotensin-(1---7) metabolism in pulmonary and renal tissues. Am J Physiol Renal Physiol. 2000 Nov; 279(5):F841-50.
    View in: PubMed
    Score: 0.034
  16. Diz DI, Kauker ML. Renal effects of indanone in dogs and rats: modification by a cyclooxygenase inhibition. Arch Int Pharmacodyn Ther. 1980 Feb; 243(2):321-30.
    View in: PubMed
    Score: 0.033
  17. South AM, Shaltout HA, Washburn LK, Hendricks AS, Diz DI, Chappell MC. Fetal programming and the angiotensin-(1-7) axis: a review of the experimental and clinical data. Clin Sci (Lond). 2019 01 15; 133(1):55-74.
    View in: PubMed
    Score: 0.030
  18. Chappell MC, Diz DI, Yunis C, Ferrario CM. Differential actions of angiotensin-(1-7) in the kidney. Kidney Int Suppl. 1998 Dec; 68:S3-6.
    View in: PubMed
    Score: 0.030
  19. Ferrario CM, Chappell MC, Tallant EA, Brosnihan KB, Diz DI. Counterregulatory actions of angiotensin-(1-7). Hypertension. 1997 Sep; 30(3 Pt 2):535-41.
    View in: PubMed
    Score: 0.028
  20. Dhaunsi GS, Yousif MH, Akhtar S, Chappell MC, Diz DI, Benter IF. Angiotensin-(1-7) prevents diabetes-induced attenuation in PPAR-gamma and catalase activities. Eur J Pharmacol. 2010 Jul 25; 638(1-3):108-14.
    View in: PubMed
    Score: 0.017
  21. Diz DI, Baer PG, Nasjletti A. Angiotensin II-induced hypertension in the rat. Effects on the plasma concentration, renal excretion, and tissue release of prostaglandins. J Clin Invest. 1983 Aug; 72(2):466-77.
    View in: PubMed
    Score: 0.010
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.